Related Experiment Video
Updated: Jul 7, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis
Jiancheng Guo1, Radha Ananthakrishnan, Wu Qu
1Department of Surgery, Columbia University Medical Center, New York, New York 10025, USA.
Abstract:
In the kidney, the receptor for advanced glycation end products (RAGE) is principally expressed in the podocyte at low levels, but is upregulated in both human and mouse glomerular diseases. Because podocyte injury is central to proteinuric states, such as the nephrotic syndrome, the murine adriamycin nephrosis model was used to explore the role of RAGE in podocyte damage. In this model, administration of the anthracycline antibiotic adriamycin provokes severe podocyte stress and glomerulosclerosis. In contrast to wild-type animals, adriamycin-treated RAGE-null mice were significantly protected from effacement of the podocyte foot processes, albuminuria, and glomerulosclerosis. Administration of adriamycin induced rapid generation of RAGE ligands, and treatment with soluble RAGE protected against podocyte injury and glomerulosclerosis. In vitro, incubation of RAGE-expressing murine podocytes with adriamycin stimulated AGE formation, and treatment with RAGE ligands rapidly activated nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase, via p44/p42 MAP kinase signaling, and upregulated pro-fibrotic growth factors. These data suggest that RAGE may contribute to the pathogenesis of podocyte injury in sclerosing glomerulopathies such as focal segmental glomerulosclerosis.
Insights
The receptor for advanced glycation end products (RAGE) exacerbates kidney podocyte injury and glomerulosclerosis. Blocking RAGE protects against adriamycin-induced nephropathy, suggesting RAGE as a therapeutic target for proteinuric kidney diseases.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Receptor for advanced glycation end products (RAGE) is upregulated in kidney glomerular diseases.
- Podocyte injury is central to proteinuric conditions like nephrotic syndrome.
Purpose of the Study:
- To investigate the role of RAGE in adriamycin-induced podocyte damage and glomerulosclerosis in a murine model.
Main Methods:
- Utilized the adriamycin nephrosis model in wild-type and RAGE-null mice.
- Assessed podocyte foot process effacement, albuminuria, and glomerulosclerosis.
- Investigated RAGE ligand generation and the effect of soluble RAGE treatment.
- Performed in vitro studies on cultured murine podocytes exposed to adriamycin and RAGE ligands.
Main Results:
- RAGE-null mice showed significant protection against adriamycin-induced podocyte injury, albuminuria, and glomerulosclerosis.
- Adriamycin treatment rapidly generated RAGE ligands; soluble RAGE administration mitigated podocyte damage.
- In vitro, adriamycin induced advanced glycation end product (AGE) formation and RAGE ligand activation of NADPH-oxidase and pro-fibrotic factors in podocytes.
Conclusions:
- RAGE signaling contributes to podocyte injury and glomerulosclerosis in experimental nephropathy.
- Targeting RAGE may offer a therapeutic strategy for proteinuric kidney diseases, including focal segmental glomerulosclerosis.
Related Concept Videos
Diabetic Nephropathy
Acute Kidney Injury II: Pathophysiology
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention

